Lee Sun Hwa, Ryoo Eell, Tchah Hann
Department of Pediatrics, Gachon University Gil Medical Center, Incheon, Korea.
Pediatr Gastroenterol Hepatol Nutr. 2017 Mar;20(1):65-70. doi: 10.5223/pghn.2017.20.1.65. Epub 2017 Mar 27.
Bannayan-Riley-Ruvalcaba syndrome (BRRS) is one of the phosphatase and tensin homolog hamartoma tumor syndrome with a gene mutation. It is a rare dominant autosomal disorder characterized by cutaneous lipomas, macrocephaly, intestinal polyps, and developmental delay. Diagnosing this syndrome is important, because it may represent the pediatric phenotype of Cowden syndrome, in which there is an increased risk for malignant tumors in children. Until now, the prevalence of BRRS is unknown. Several dozen cases have been reported in the medical literature, but no case has been reported in Korea. Here we report a case of a 19-year-old girl who was diagnosed with BRRS because of macrocephaly, intellectual disability, and intestinal polyps. Her mother had similar findings and a mutation. Neither patient had mutations detected by conventional mutation-detection techniques, but a gene deletion was demonstrated by chromosomal microarray analysis.
班纳扬-莱利-鲁瓦尔卡瓦综合征(BRRS)是一种因基因突变导致的磷酸酶和张力蛋白同源物错构瘤肿瘤综合征。它是一种罕见的常染色体显性疾病,其特征为皮肤脂肪瘤、巨头畸形、肠息肉和发育迟缓。诊断该综合征很重要,因为它可能代表考登综合征的儿科表型,而患有考登综合征的儿童患恶性肿瘤的风险会增加。到目前为止,BRRS的患病率尚不清楚。医学文献中已报道了几十例病例,但韩国尚未有病例报告。在此,我们报告一例19岁女孩,因其巨头畸形、智力残疾和肠息肉被诊断为BRRS。她的母亲有类似表现且存在一种突变。两名患者通过传统突变检测技术均未检测到突变,但染色体微阵列分析显示存在一种基因缺失。